Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Softwar… (NCT07027358) | Clinical Trial Compass
TerminatedNot Applicable
Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Software, in the Care and Support of Elderly People Living in Nursing Homes
Stopped: Sponsor's decision
France30 participantsStarted 2024-09-03
Plain-language summary
NETSmart software is designed to help doctors, nurses and care assistants adapt the care of elderly people living in nursing homes to the following risks:
* pressure injuries
* undernutrition
* interactions between different drugs
* falls. The software analyzes the information in your medical records, alerts your medical team to any points of vigilance, and suggests appropriate recommendations.
The study comprises 2 distinct phases:
* An initial 4-month phase, during which the medical staff will simply assess whether the NETSmart software's recommendations are relevant, without changing their current practice, i.e. they will continue to care for you as usual;
* A second 6-month phase, during which your caregivers will follow the software's recommendations if they feel they are relevant, and potentially adapt your care.
Who can participate
Age range
70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female, at least 70 years old
* Permanent resident at an investigation site for at least 6 months.
* Considered an at-risk patient, i.e. meeting at least one of the following criteria :
* Braden score \< 16
* At risk of pressure ulcer according to the investigator's judgment
* At risk of undernutrition as judged by the investigator
* Undergoing at least 6 drug treatments
* At risk of falls as judged by the investigator
* Affiliated with the French social security system
* Having given informed, dated and signed consent to participate in the investigation
Exclusion Criteria:
* Patient with a life expectancy of less than 2 months as judged by the investigator
* Patient who is participating or has participated in another investigation or study involving the use of a medical device or drug within 30 days prior to inclusion
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Percentage of clinically relevant recommandations provided by NETSmart